Tag: colonoscopy

May 8, 2018

Immuron Reports Significant Alleviation of Colitis Symptoms in Preclinical Program

Immuron (ASX:IMC) (NASDAQ:IMRN), an Australian microbiome biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the...
February 14, 2018

Motus Goes Public on the NASDAQ

Medical device company, Motus (NASDAQ:MOTS), made the switch from private to public today on the NASDAQ Capital market, but Renaissance...
February 22, 2017

Microbot Medical Inc. Announces Significant Technology Patent Allowance in the U.S.

Microbot Medical Inc. (Nasdaq:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today...
January 9, 2017

Exact Sciences to report $99 million in revenues, 150 percent growth for 2016

Exact Sciences Corp. (Nasdaq: EXAS) announced today that the company expects to report revenues between $34.9 million and $35.4 million...
January 5, 2017

Microbot Medical Inc. Announces $3.5 Million Registered Direct Offering

Microbot Medical Inc. (NasdaqCM:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, announced...
October 19, 2016

Paion Presents Positive Remimazolam Phase III Colonoscopy Results at the 2016 American College of Gastroenterology Annual Scientific Meeting

Paion, a specialty pharma company, today announces that data on the clinical results of remimazolam's U.S. Phase III colonoscopy trial...